세계의 덤핑 증후군 시장 보고서(2025년)
Dumping Syndrome Global Market Report 2025
상품코드 : 1824649
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,430,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,294,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,159,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

세계의 덤핑 증후군 시장 규모는 향후 몇 년 동안 강력한 성장이 예상됩니다. 2029년까지 CAGR 10.0%로 확대되어 19억 9,000만 달러로 성장할 것으로 예상됩니다. 예측 기간의 성장은 체중 감량 수술 동향, 개인화 치료 접근법, 영양 및 식이 개입, 원격 의료 및 원격 모니터링에 기인합니다. 예측기간의 주요 동향에는 저침습 수술 기술, 데이터 분석과 AI, 협업 증가, 예방 대책 등이 포함됩니다.

향후 5년간의 성장률 10.0%라는 예측은 지난 예측으로부터 0.1% 소폭 감소를 반영하고 있습니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향 때문입니다. 관세 장벽은 네덜란드와 스웨덴에서 수입되는 위 배출 신티그래피 키트 및 지속 포도당 모니터의 가격을 상승시키고 진단 및 관리를 지연시킴으로써 수술 후 관리를 복잡하게 할 수 있습니다. 또한 상호관세와 무역 긴장과 한계 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향이 보다 광범위하게 이어질 수 있습니다.

상부 위장관(GI) 질환의 유병률 증가는 향후 수년간 덤핑 증후군 시장 성장의 중요한 촉진요인이 될 것으로 예측됩니다. 상부 위장관 질환은 식도, 위, 소장의 초기 부분(십이지장)을 포함한 소화기계의 상부에 영향을 미치는 질환입니다. 덤핑 증후군은 특정 위장관(GI) 수술, 특히 위, 십이지장, 유문 괄약근을 비롯한 수술을 받은 후에 나타날 수 있는 질병입니다. 예를 들어, 2023년 4월 현재 미국 국립의료도서관은 상부 소화관 출혈(UGIB)이 유행하고 있는 문제이며, 추정 발생률은 연간 10만명당 80-150례라고 보고하고 있습니다. 사망률은 2-15%로 추정되며, UGIB는 급성 위장(GI) 출혈의 전체 사례의 75%를 차지합니다. 따라서 상부 위장관 질환의 유병률 증가는 덤핑 증후군 시장 성장의 원동력이 되고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별/국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 전략

제36장 부록

JHS
영문 목차

영문목차

Dumping syndrome, also referred to as rapid gastric emptying, is a medical condition characterized by the swift emptying of the stomach's contents into the small intestine. This often results in uncomfortable, and in some cases, severe symptoms. It is commonly observed following specific stomach surgeries, particularly gastric bypass or partial gastrectomy.

The primary types of diagnoses for dumping syndrome encompass blood sugar tests, gastric emptying tests, and medical histories, among others. A blood sugar test, also known as a blood glucose test, is a medical examination utilized to gauge the concentration of glucose (sugar) in an individual's bloodstream. Treatment options encompass medication, surgery, and other modalities, which can be administered through various routes like oral, intravenous, and others. These treatments are employed to address different phases of the condition, including both the early and late dumping phases. The services are availed by a range of end-users, including hospitals, clinics, research laboratories, and others.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The dumping syndrome market research report is one of a series of new reports from The Business Research Company that provides dumping syndrome market statistics, including dumping syndrome industry global market size, regional shares, competitors with a dumping syndrome market share, detailed dumping syndrome market segments, market trends and opportunities and any further data you may need to thrive in the dumping syndrome industry. This dumping syndrome market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The dumping syndrome market size has grown strongly in recent years. It will grow from $1.24 billion in 2024 to $1.36 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to gastric surgery procedures, increased prevalence of obesity, advancements in surgical techniques, improved diagnostic methods.

The dumping syndrome market size is expected to see strong growth in the next few years. It will grow to $1.99 billion in 2029 at a compound annual growth rate (CAGR) of 10.0%. The growth in the forecast period can be attributed to weight loss surgery trends, personalized treatment approaches, nutritional and dietary interventions, telemedicine and remote monitoring. Major trends in the forecast period include minimally invasive surgical techniques, data analytics and ai, increased collaboration, preventive measures.

The forecast of 10.0% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers may complicate post-surgical care by increasing prices of gastric emptying scintigraphy kits and continuous glucose monitors imported from the Netherlands and Sweden, delaying diagnosis and management. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing prevalence of upper gastrointestinal (GI) diseases is anticipated to be a significant driver for the growth of the dumping syndrome market in the coming years. Upper GI diseases pertain to disorders that affect the upper segment of the digestive system, encompassing the esophagus, stomach, and the initial section of the small intestine (duodenum). Dumping syndrome is a condition that can manifest after individuals undergo specific upper gastrointestinal (GI) surgeries, particularly those involving the stomach, duodenum, or pyloric sphincter. For instance, as of April 2023, the National Library of Medicine reported that upper gastrointestinal bleeding (UGIB) constitutes a prevalent issue, with an estimated incidence rate ranging from 80 to 150 cases per 100,000 individuals annually. Mortality rates are estimated to range from 2 to 15 percent, and UGIB accounts for 75% of all cases of acute gastrointestinal (GI) bleeding. Consequently, the increasing prevalence of upper GI diseases stands as a driving force behind the growth of the dumping syndrome market.

Increasing investment in the healthcare sector is expected to support the growth of the dumping syndrome market. Healthcare infrastructure encompasses spending on medical care, preventive services, public health initiatives, rehabilitation, community health activities, and medical research. This spending is crucial for advancing dumping syndrome treatments by enabling access to a range of medical diagnoses and therapies. For example, in July 2024, the American Medical Association reported that U.S. health spending in 2022 rose by 4.1%, totaling $4.5 trillion, which amounts to $13,493 per person. Consequently, rising healthcare sector investment is contributing to growth in the dumping syndrome market.

Key players in the Dumping Syndrome market are focused on developing innovative solutions, such as bariatric surgery, to enhance patient outcomes. Bariatric surgery encompasses various procedures designed to help individuals with obesity achieve significant weight loss. For example, in May 2024, Blackrock WeightCare, a weight loss service based in Ireland, introduced the Single Anastomosis Duodeno-Ileal Bypass with Sleeve Gastrectomy (SADI-S). This cutting-edge surgery combines sleeve gastrectomy with a partial intestinal bypass, providing an effective treatment for patients with severe obesity, particularly those with a BMI over 45. The SADI-S procedure, which uses robotic technology, is expected to deliver improved weight loss results while reducing complications like dumping syndrome. Additionally, Blackrock WeightCare offers comprehensive aftercare to ensure long-term patient success.

Leading companies in the dumping syndrome market are focusing on advancing endoscopy services, including the use of AI-supported equipment, to improve examination accuracy and patient comfort. For example, in January 2024, Docrates Cancer Center, a private hospital in Finland, introduced gastrointestinal endoscopy services. This initiative aims to meet the growing demand for early cancer detection and diagnostic exams, specifically for the esophagus, stomach, and colon. The service features thorough examinations enhanced by AI technology to support more precise diagnostics.

Major companies operating in the dumping syndrome market are Cardinal Health Inc., Johnson & Johnson Private Limited, Abbott Laboratories Inc., Medtronic PLC, Covidien PLC, Fujifilm Holdings Corporation, Stryker Corporation, Allergan PLC, Boston Scientific Corporation, B. Braun Melsungen AG, Olympus Corporation, Intuitive Surgical Inc., Terumo Corporation, Steris Corporation, Teleflex Medical Europe Ltd., Cook Medical Inc., Karl Storz SE & Co. KG, Conmed Corporation, Applied Medical Resources Corporation, Richard Wolf GmbH, Pentax Medical Company, GI Dynamics, EndoGastric Solutions Inc., Apollo Endosurgery Inc., EndoChoice Holdings Inc., Cousin Biotech, Mediflex Surgical Product, Asensus Surgical Inc., USGI Medical Inc., TransEnterix Inc.

North America was the largest region in the dumping syndrome market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in dumping syndrome report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the dumping syndrome market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The dumping syndrome market consists of revenues earned by entities by providing endoscopy, surgical interventions and dietary services. The market value includes the value of related goods sold by the service provider or included within the service offering. The dumping syndrome market also includes sales of Acarbose and Octreotide drugs. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Dumping Syndrome Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on dumping syndrome market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for dumping syndrome ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The dumping syndrome market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Dumping Syndrome Market Characteristics

3. Dumping Syndrome Market Trends And Strategies

4. Dumping Syndrome Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Dumping Syndrome Growth Analysis And Strategic Analysis Framework

6. Dumping Syndrome Market Segmentation

7. Dumping Syndrome Market Regional And Country Analysis

8. Asia-Pacific Dumping Syndrome Market

9. China Dumping Syndrome Market

10. India Dumping Syndrome Market

11. Japan Dumping Syndrome Market

12. Australia Dumping Syndrome Market

13. Indonesia Dumping Syndrome Market

14. South Korea Dumping Syndrome Market

15. Western Europe Dumping Syndrome Market

16. UK Dumping Syndrome Market

17. Germany Dumping Syndrome Market

18. France Dumping Syndrome Market

19. Italy Dumping Syndrome Market

20. Spain Dumping Syndrome Market

21. Eastern Europe Dumping Syndrome Market

22. Russia Dumping Syndrome Market

23. North America Dumping Syndrome Market

24. USA Dumping Syndrome Market

25. Canada Dumping Syndrome Market

26. South America Dumping Syndrome Market

27. Brazil Dumping Syndrome Market

28. Middle East Dumping Syndrome Market

29. Africa Dumping Syndrome Market

30. Dumping Syndrome Market Competitive Landscape And Company Profiles

31. Dumping Syndrome Market Other Major And Innovative Companies

32. Global Dumping Syndrome Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Dumping Syndrome Market

34. Recent Developments In The Dumping Syndrome Market

35. Dumping Syndrome Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기